Clinicopathological Correlations and Cholinesterase Expression in Early-Onset Familial Alzheimer's Disease with the Presenilin 1 Mutation, Leu235Pro

Disentangling heterogeneity in Alzheimer’s disease and related dementias using data-driven methods

(2020) Mohamad Habes et al.   BIOLOGICAL PSYCHIATRY

Normative Cognitive Decline in Old Age

(2020) Robert S. Wilson et al.   ANNALS OF NEUROLOGY

Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the Rush Memory and Aging Project

(2019) Lindsay M K Wallace et al.   LANCET NEUROLOGY

Lewy Body P:athology in Alzheimer's Disease: A Clinicopathological Prospective Study

(2018) Rodolfo Savica et al.   ACTA NEUROLOGICA SCANDINAVICA

Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies

(2018) Patricia A. Boyle et al.   ANNALS OF NEUROLOGY

Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease

(2017) Ian R. Macdonald et al.   JOURNAL OF ALZHEIMERS DISEASE

Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus

(2017) H. Hamodat et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model

(2016) S. Darvesh et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Original article Laminar distribution of β-amyloid (Aβ) peptide deposits in the frontal lobe in familial and sporadic Alzheimer’s disease

(2015) Richard A. Armstrong   FOLIA NEUROPATHOLOGICA

Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model

(2015) G. Andrew Reid et al.   NEUROSCIENCE

Clinical Features of Alzheimer Disease With and Without Lewy Bodies

(2015) Eun Joo Chung et al.   JAMA Neurology

Early-Onset Familial Alzheimer's Disease (EOFAD)

(2014) Liyong Wu et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging

(2013) Keith A. Johnson et al.   Alzheimers & Dementia

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

(2013) V K Ramanan et al.   MOLECULAR PSYCHIATRY

Locus-specific mutation databases for neurodegenerative brain diseases

(2012) Marc Cruts et al.   HUMAN MUTATION

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Butyrylcholinesterase Is Associated With β-Amyloid Plaques in the Transgenic APPSWE/PSEN1dE9 Mouse Model of Alzheimer Disease

(2011) Sultan Darvesh et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease

(2011) Anna Antonell et al.   NEUROSCIENCE LETTERS

Alzheimer's Disease: The Challenge of the Second Century

(2011) D. M. Holtzman et al.   Science Translational Medicine

Biochemical and Histochemical Comparison of Cholinesterases in Normal and Alzheimer Brain Tissues

(2010) S. Darvesh et al.   Current Alzheimer Research

Amyloid-β-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Aβ peptide. Implications for the pathogenesis of Alzheimer's disease

(2010) Margarita C Dinamarca et al.   Molecular Neurodegeneration

Variations in the neuropathology of familial Alzheimer’s disease

(2009) Claire Shepherd et al.   ACTA NEUROPATHOLOGICA

Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations

(2008) Chera L Maarouf et al.   Molecular Neurodegeneration